Estimation of outpatient SARS-CoV-2 reinfection and recurrence rates and associated factors among COVID-19 hospitalized patients over one-year old: a multicenter retrospective cohort study

被引:1
|
作者
Mokhayeri, Yaser [1 ]
Taherpour, Niloufar [2 ]
Shahbazi, Fatemeh [3 ]
Ghorbani, Sahar Sotoodeh [4 ]
Fallah, Saeid [5 ]
Etemad, Koorosh [4 ]
Izadi, Neda [6 ]
Mehri, Ahmad [4 ]
Farhadi-Babadi, Kosar [4 ]
Rahimi, Elham [4 ]
Feyzi, Rezvan [4 ]
Seifi, Arash [7 ]
Nazari, Seyed Saeed Hashemi [8 ]
机构
[1] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran
[2] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Tehran, Iran
[3] Hamadan Univ Med Sci Hamadan, Sch Hlth, Dept Epidemiol, Hamadan, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Golestan Univ Med Sci, Hlth Management & Social Dev Res Ctr, Gorgan, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran
[7] Univ Tehran Med Sci, Fac Med, Dept Infect Dis, Tehran, Iran
[8] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Sch Publ Hlth & Safety, Dept Epidemiol, Daneshjoo Blvd,Evin Ave, Tehran 1983535511, Iran
关键词
SARS-Cov-2; Reinfection; Recurrence; Out-patient; Iran; RISK-FACTORS; INFECTION;
D O I
10.1186/s12879-024-09872-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionReinfection with SARS-Cov-2 after recovery can occur that most of them don't require hospitalization. The aim of this study is estimation of out-patient COVID-19 reinfection and recurrence rates and its associated factors among Iranian patients with history of confirmed SARS-Cov-2 infection and hospitalization.MethodsThis study is a retrospective cohort conducted from May 2021 to May 2022 in Iran. The national Medical Care Monitoring Center (MCMC) database, obtained from the Ministry of Health and Medical Education, includes all information about confirmed COVID-19 patients who are hospitalized and diagnosed during the pandemic. Using probability proportional to size sampling from 31 provinces, 1,532 patients over one years of age with a history of hospitalization in the MCMC data are randomly selected. After that, interviews by phone are performed with all of the selected patients using a researcher-made questionnaire about the occurrence of overall reinfection without considering the time of infection occurrence, reinfection occurring at least 90 days after the discharge and recurrence (occurring within 90 days after discharge). Univariate and multivariable Cox regression analyses are performed to assess the factors associated with each index. All of the analyses are performed using Stata software version 16.ResultsIn general, 1,532 phone calls are made, out of which 1,095 individuals are willing to participate in the study (response rate similar or equal to 71%). After assessing the 1,095 patients with a positive history of COVID-19, the rates of non-hospitalized overall SARS-Cov-2 reinfection, reinfection and recurrence are 122.64, 114.09, and 8.55 per 1,000 person-years, respectively. The age range of 19-64 years (aHR:3.93, 95%CI : 1.24-12.41) and COVID-19-related healthcare worker (aHR: 3.67, 95%CI: 1.77-7.61) are identified as risk factors for reinfection, while having comorbidity, being fully vaccinated, and having a partial pressure of oxygen (PaO2) >= 93 mmHg during the initial infection are identified as factors that reduce the risk of non-hospitalized reinfection.ConclusionReinfection due to COVID-19 is possible because of the weakened immune system for various reasons and the mutation of the virus. Vaccination, timely boosters, and adherence to preventive measures can help mitigate this risk.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study
    Taherpour, Niloufar
    Etemad, Koorosh
    Mokhayeri, Yaser
    Fallah, Saeid
    Ghorbani, Sahar Sotoodeh
    Izadi, Neda
    Rahimi, Elham
    Shahbazi, Fatemeh
    Seifi, Arash
    Mehri, Ahmad
    Feyzi, Rezvan
    Farhadi-Babadi, Kosar
    Nazari, Seyed Saeed Hashemi
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2024, 12 (01)
  • [2] Factors Associated with Mortality among Hospitalized Patients with COVID-19: A Retrospective Cohort Study
    Martins-Filho, Paulo Ricardo
    de Souza Araujo, Adriano Antunes
    Pereira, Luciana Xavier
    Quintans-Junior, Lucindo Jose
    Barboza, Waneska de Souza
    Cavalcante, Taise Ferreira
    de Souza, Mercia Feitosa
    de Oliveira Goes, Marco Aurelio
    Santos, Victor Santana
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (01): : 103 - 105
  • [3] Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective
    Miao, Miao
    Clercq, Erik De
    Li, Guangdi
    BIOMEDICINES, 2021, 9 (04)
  • [4] Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study
    Lu, Yun
    Yang, Qing-qing
    Zhuo, Lin
    Yang, Kun
    Kou, Hao
    Gao, Su-yu
    Hu, Wen
    Jiang, Qiao-li
    Li, Wen-jing
    Wu, Dong-fang
    Sun, Feng
    Cheng, Hong
    Zhan, Siyan
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [5] Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2
    Colaneri, Marta
    Canuti, Marta
    Torrigiani, Ginevra
    Dall'Olio, Lucia
    Bobbio, Chiara
    Baldi, Sante L.
    Nobili, Alessandro
    Puoti, Massimo
    Marchetti, Giulia
    Piva, Simone
    Plebani, Pierluigi
    Raviglione, Mario
    Gori, Andrea
    Cereda, Danilo
    Leoni, Olivia
    Fortino, Ida
    Ojeda-Fernandez, Maria Luisa
    Baviera, Marta
    Tettamanti, Mauro
    Bandera, Alessandra
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (02) : 447 - 461
  • [6] Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study
    Mo, Pingzheng
    Deng, Liping
    Liu, Xiaoping
    Gao, Shicheng
    Liang, Ke
    Luo, Mingqi
    Chen, Tielong
    Song, Shihui
    Ma, Zhiyong
    Chen, Xiaoping
    Fan, Junli
    Wang, Fan
    Xiong, Yong
    Zhang, Yongxi
    EPIDEMIOLOGY & INFECTION, 2020, 148
  • [7] One-year mortality and associated factors in older hospitalized COVID-19 survivors: a Nationwide Cohort Study in Korea
    Kim, Eunji
    Kim, Jeong-Yeon
    Moon, Kyoung Min
    Kim, Tae Wan
    Kim, Won-Young
    Jung, Sun-Young
    Baek, Moon Seong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients A multicenter retrospective cohort study
    Wu, Xinxin
    Zhou, Shuang
    Liu, Changya
    Huang, Tingrong
    Zheng, You
    Zhang, Wen
    Qu, Yao
    Fang, Bangjiang
    MEDICINE, 2021, 100 (40) : E27410
  • [9] SARS-COV-2 (COVID-19) ANOSMIA IN PATIENTS WITH OBESITY: A RETROSPECTIVE STUDY
    Sarantis, N.
    Vlachopoulou, M.
    Chatzis, G.
    ATHEROSCLEROSIS, 2021, 331 : E210 - E210
  • [10] Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
    Qian, Grace
    Wang, Xiaosong
    Patel, Naomi J.
    Kawano, Yumeko
    Fu, Xiaoqing
    Cook, Claire E.
    Vanni, Kathleen M. M.
    Kowalski, Emily N.
    Banasiak, Emily P.
    Bade, Katarina J.
    Srivatsan, Shruthi
    Williams, Zachary K.
    Todd, Derrick J.
    Weinblatt, Michael E.
    Wallace, Zachary S.
    Sparks, Jeffrey A.
    LANCET RHEUMATOLOGY, 2023, 5 (03): : E139 - E150